Mesothelioma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Mesothelioma}}
{{Mesothelioma}}
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{PSD}}, {{SR}}, {{FA}}


==Overview==
==Overview==
The association between mesothelioma and asbestos exposure was first described by Dr. Wagner in his seminal study of South African miners. It was discovered later that people who live near to factors and mines developed mesothelioma despite not working in the mines.


==Historical Perspective==
==Historical Perspective==
The first lawsuit against asbestos manufacturers was brought in 1929. The parties settled that lawsuit, and as part of the agreement, the attorneys agreed not to pursue further cases. It was not until 1960 that an article published by Wagner et al first officially established mesothelioma as a disease arising from exposure to crocidolite asbestos.<ref name="marchand">"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province" by J. C. Wagner, C. A. Sleggs and P. Marchand in ''Br J Ind Med.'' (1960) volume 17, pages 260-271 {{Entrez Pubmed|13782506}}.</ref> The article referred to over 30 case studies of people who had suffered from mesothelioma in South Africa. Some exposures were transient and some were mine workers. In 1962 McNulty reported the first diagnosed case of malignant mesothelioma in an [[Australia]]n asbestos worker.<ref name="mcnulty">"Malignant pleural mesothelioma in an asbestos worker" by J. C. McNulty in ''Med J Aust'' (1962) volume 49, pages 953-954 {{Entrez Pubmed|13932248}}.</ref> The worker had worked in the mill at the asbestos mine in [[Wittenoom, Western Australia|Wittenoom]] from 1948 to 1950.
*The association between mesothelioma and exposure to asbestos fibers was elucidated by Dr. Wagner in his seminal study of South African miners.<ref name="ThomasChen2015">{{cite journal|last1=Thomas|first1=Anish|last2=Chen|first2=Yuanbin|last3=Yu|first3=Tinghui|last4=Gill|first4=Ammara|last5=Prasad|first5=Vinay|title=Distinctive clinical characteristics of malignant mesothelioma in young patients|journal=Oncotarget|volume=6|issue=18|year=2015|pages=16766–16773|issn=1949-2553|doi=10.18632/oncotarget.4414}}</ref>  
 
*In the town of Wittenoom, asbestos-containing mine waste was used to cover schoolyards and playgrounds.
In the town of Wittenoom, asbestos-containing mine waste was used to cover schoolyards and playgrounds. In 1965 an article in the British Journal of Industrial Medicine established that people who lived in the neighbourhoods of asbestos factories and mines, but did not work in them, had contracted mesothelioma.  
*In 1965, an article in the British Journal of Industrial Medicine established that people who lived in the neighborhoods of asbestos factories and mines, but did not work in them, had contracted mesothelioma.  
 
*Despite proof that the dust associated with asbestos mining and milling causes asbestos related disease, mining began at Wittenoom in 1943 and continued until 1966. In 1974 the first public warnings of the dangers of blue asbestos were published in a cover story called "Is this Killer in Your Home?" in Australia's ''Bulletin'' magazine. In 1978, the Western Australian Government decided to phase out the town of Wittenoom, following the publication of a Health Dept. booklet, "The Health Hazard at Wittenoom", containing the results of air sampling and an appraisal of worldwide medical information.  
Despite proof that the dust associated with asbestos mining and milling causes asbestos related disease, mining began at Wittenoom in 1943 and continued until 1966. In 1974 the first public warnings of the dangers of blue asbestos were published in a cover story called "Is this Killer in Your Home?" in Australia's ''Bulletin'' magazine. In 1978 the Western Australian Government decided to phase out the town of Wittenoom, following the publication of a Health Dept. booklet, "The Health Hazard at Wittenoom", containing the results of air sampling and an appraisal of worldwide medical information.  
*By 1979 the first writs for negligence related to Wittenoom were issued against CSR and its subsidiary ABA, and the Asbestos Diseases Society was formed to represent the Wittenoom victims.
 
*In the landmark study by Vogelzang et al., [[cisplatin]] and [[pemetrexed]] led to an objective response rate of 41% and median survival of 12.1 months, compared to 17% and 9.3 months in patients treated with [[cisplatin]] alone.<ref name="Saint-PierrePease2015">{{cite journal|last1=Saint-Pierre|first1=Mathieu D.|last2=Pease|first2=Christopher|last3=Mithoowani|first3=Hamid|last4=Zhang|first4=Tinghua|last5=Nicholas|first5=Garth A.|last6=Laurie|first6=Scott A.|last7=Wheatley-Price|first7=Paul|title=Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy|journal=Lung Cancer International|volume=2015|year=2015|pages=1–7|issn=2090-3197|doi=10.1155/2015/590148}}</ref>
By 1979 the first writs for negligence related to Wittenoom were issued against CSR and its subsidiary ABA, and the Asbestos Diseases Society was formed to represent the Wittenoom victims.


==Legal issues==
==Legal issues==
 
* The first lawsuits against asbestos manufacturers were in 1929.  
The first lawsuits against asbestos manufacturers were in 1929. Since then, many lawsuits have been filed against  asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known (some reports seem to place this [[Asbestos#Asbestosis and cancer|as early as 1898]]).  The liability resulting from the sheer number of lawsuits and people affected has reached billions of dollars. The amounts and method of allocating compensation have been the source of many court cases, and government attempts at resolution of existing and future cases.
* Since then, many lawsuits have been filed against  asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known (some reports seem to place this [[Asbestos#Asbestosis and cancer|as early as 1898]]).   
* The liability resulting from the sheer number of lawsuits and people affected has reached billions of dollars.  
* The amounts and method of allocating compensation have been the source of many court cases, and government attempts at resolution of existing and future cases.
{{main|asbestos and the law}}
{{main|asbestos and the law}}


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
Line 30: Line 29:
[[Category:Asbestos]]
[[Category:Asbestos]]
[[Category:Occupational diseases]]
[[Category:Occupational diseases]]
[[Category:Oncology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 16:32, 9 April 2019

Mesothelioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesothelioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Summary of Treatment for Pleural Mesothelioma

Summary of Treatment for Peritoneal Mesothelioma

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesothelioma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesothelioma historical perspective

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesothelioma historical perspective

CDC on Mesothelioma historical perspective

Mesothelioma historical perspective in the news

Blogs on Mesothelioma historical perspective

Directions to Hospitals Treating Mesothelioma

Risk calculators and risk factors for Mesothelioma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Sujit Routray, M.D. [3], Fatima Shaukat, MD [4]

Overview

The association between mesothelioma and asbestos exposure was first described by Dr. Wagner in his seminal study of South African miners. It was discovered later that people who live near to factors and mines developed mesothelioma despite not working in the mines.

Historical Perspective

  • The association between mesothelioma and exposure to asbestos fibers was elucidated by Dr. Wagner in his seminal study of South African miners.[1]
  • In the town of Wittenoom, asbestos-containing mine waste was used to cover schoolyards and playgrounds.
  • In 1965, an article in the British Journal of Industrial Medicine established that people who lived in the neighborhoods of asbestos factories and mines, but did not work in them, had contracted mesothelioma.
  • Despite proof that the dust associated with asbestos mining and milling causes asbestos related disease, mining began at Wittenoom in 1943 and continued until 1966. In 1974 the first public warnings of the dangers of blue asbestos were published in a cover story called "Is this Killer in Your Home?" in Australia's Bulletin magazine. In 1978, the Western Australian Government decided to phase out the town of Wittenoom, following the publication of a Health Dept. booklet, "The Health Hazard at Wittenoom", containing the results of air sampling and an appraisal of worldwide medical information.
  • By 1979 the first writs for negligence related to Wittenoom were issued against CSR and its subsidiary ABA, and the Asbestos Diseases Society was formed to represent the Wittenoom victims.
  • In the landmark study by Vogelzang et al., cisplatin and pemetrexed led to an objective response rate of 41% and median survival of 12.1 months, compared to 17% and 9.3 months in patients treated with cisplatin alone.[2]

Legal issues

  • The first lawsuits against asbestos manufacturers were in 1929.
  • Since then, many lawsuits have been filed against asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known (some reports seem to place this as early as 1898).
  • The liability resulting from the sheer number of lawsuits and people affected has reached billions of dollars.
  • The amounts and method of allocating compensation have been the source of many court cases, and government attempts at resolution of existing and future cases.

References

  1. Thomas, Anish; Chen, Yuanbin; Yu, Tinghui; Gill, Ammara; Prasad, Vinay (2015). "Distinctive clinical characteristics of malignant mesothelioma in young patients". Oncotarget. 6 (18): 16766–16773. doi:10.18632/oncotarget.4414. ISSN 1949-2553.
  2. Saint-Pierre, Mathieu D.; Pease, Christopher; Mithoowani, Hamid; Zhang, Tinghua; Nicholas, Garth A.; Laurie, Scott A.; Wheatley-Price, Paul (2015). "Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy". Lung Cancer International. 2015: 1–7. doi:10.1155/2015/590148. ISSN 2090-3197.


Template:WikiDoc Sources